Asthma insights and reality in the United Arab Emirates.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 2954375)

Published in Ann Thorac Med on October 01, 2010

Authors

Bassam Hassan Saleh Hassan Mahboub1, Sonia Santhakumar, Joan B Soriano, Ruby Pawankar

Author Affiliations

1: Department of Pulmonology, Rashid Hospital, Dubai, P.O. Box 4545, United Arab Emirates. drmahboub@yahoo.com

Articles cited by this

Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis (1978) 14.41

Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J (2008) 10.08

The global burden of asthma. Chest (2006) 5.74

Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J (2000) 5.54

Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol (2006) 4.80

Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol (2004) 4.17

Childhood asthma and poverty: differential impacts and utilization of health services. Pediatrics (1993) 3.42

Poverty, race, and hospitalization for childhood asthma. Am J Public Health (1988) 2.79

Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest (2000) 2.18

Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. J Allergy Clin Immunol (2003) 2.04

Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. J Allergy Clin Immunol (2002) 1.98

Asthma control in Latin America: the Asthma Insights and Reality in Latin America (AIRLA) survey. Rev Panam Salud Publica (2005) 1.78

Comparison of asthma prevalence in the ISAAC and the ECRHS. ISAAC Steering Committee and the European Community Respiratory Health Survey. International Study of Asthma and Allergies in Childhood. Eur Respir J (2000) 1.57

Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol (2007) 1.50

Outcome of asthma: longitudinal changes in lung function. Eur Respir J (1999) 1.15

Changing prevalence of asthma and allergic diseases among Kuwaiti children. An ISAAC Study (Phase III). Med Princ Pract (2008) 0.88

Prevalence of asthma among Emirates school children. Eur J Epidemiol (1994) 0.81

[Asthma Insights & Reality in Japan 2005]. Arerugi (2006) 0.79

Articles by these authors

(truncated to the top 100)

Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol (2004) 4.17

Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N Engl J Med (2015) 4.16

Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol (2004) 3.49

Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index. Chest (2014) 2.80

[Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease in Spanish Internal Medicine services. ECCO study]. Med Clin (Barc) (2011) 2.61

The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med (2009) 2.60

Multicomponent indices to predict survival in COPD: the COCOMICS study. Eur Respir J (2012) 2.18

Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med (2010) 2.09

Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. J Allergy Clin Immunol (2003) 2.04

Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg (2004) 2.01

WAO Guideline for the Management of Hereditary Angioedema. World Allergy Organ J (2012) 1.96

Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res (2010) 1.79

Asthma control in Latin America: the Asthma Insights and Reality in Latin America (AIRLA) survey. Rev Panam Salud Publica (2005) 1.78

Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol (2012) 1.68

A global survey of changing patterns of food allergy burden in children. World Allergy Organ J (2013) 1.66

Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy (2009) 1.65

Recent improvement in long-term survival after a COPD hospitalisation. Thorax (2010) 1.65

New GOLD classification: longitudinal data on group assignment. Respir Res (2014) 1.64

An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63

Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med (2013) 1.63

Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias. Am J Respir Crit Care Med (2005) 1.60

Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51

A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J (2013) 1.51

Is spirometry properly used to diagnose COPD? Results from the BOLD study in Salzburg, Austria: a population-based analytical study. Prim Care Respir J (2013) 1.51

Nasal polyposis: an update: editorial review. Curr Opin Allergy Clin Immunol (2003) 1.49

Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions. Arch Bronconeumol (2013) 1.47

Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur Respir J (2012) 1.43

Gender differences in the management and experience of Chronic Obstructive Pulmonary Disease. Respir Med (2004) 1.37

Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest (2012) 1.33

Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol (2006) 1.33

Nosocomial outbreak of Corynebacterium striatum infection in patients with chronic obstructive pulmonary disease. J Clin Microbiol (2007) 1.33

Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. J Allergy Clin Immunol (2013) 1.33

The biodiversity hypothesis and allergic disease: world allergy organization position statement. World Allergy Organ J (2013) 1.32

Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery. Arch Bronconeumol (2012) 1.29

Allergic diseases and asthma: a major global health concern. Curr Opin Allergy Clin Immunol (2012) 1.26

ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol (2006) 1.26

COPD as a systemic disease. COPD (2008) 1.23

Chronic obstructive pulmonary disease in the United Kingdom: trends in mortality, morbidity, and smoking. Curr Opin Pulm Med (2002) 1.18

Asthma control in adults in Asia-Pacific. Respirology (2005) 1.17

A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC). Prim Care Respir J (2013) 1.16

Determinants of Underdiagnosis of COPD in National and International Surveys. Chest (2015) 1.14

Prediction of risk of COPD exacerbations by the BODE index. Respir Med (2008) 1.09

Mast cells in basal cell carcinoma express VEGF, IL-8 and RANTES. Int Arch Allergy Immunol (2003) 1.07

Allergic rhinitis and co-morbid asthma: perspective from India -- ARIA Asia-Pacific Workshop report. Asian Pac J Allergy Immunol (2009) 1.05

Recommendations for competency in allergy training for undergraduates qualifying as medical practitioners: a position paper of the world allergy organization. World Allergy Organ J (2009) 1.04

Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking. Respir Med (2008) 1.04

The proportional Venn diagram of obstructive lung disease in the Italian general population. Chest (2004) 1.04

Validation of a chronic obstructive pulmonary disease screening questionnaire for population surveys. Respir Med (2004) 1.04

Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD. Chest (2015) 1.03

Sub-lingual immunotherapy: world allergy organization position paper 2009. World Allergy Organ J (2009) 1.03

Increased expression and role of thymic stromal lymphopoietin in nasal polyposis. Allergy Asthma Immunol Res (2011) 1.03

Telomere shortening in sleep apnea syndrome. Respir Med (2010) 1.01

Quality of life assessment in Thai patients with allergic rhinoconjunctivitis using the SF-36 questionnaire (Thai version). Rhinology (2005) 1.00

Geographic differences in clinical characteristics and management of COPD: the EPOCA study. Int J Chron Obstruct Pulmon Dis (2008) 0.98

Identification of a novel Cochlin isoform in the perilymph: insights to Cochlin function and the pathogenesis of DFNA9. Biochem Biophys Res Commun (2004) 0.96

Prognosis of COPD patients requiring frequent hospitalization: role of airway infection. Respir Med (2010) 0.96

Rhinosinusitis: Developing guidance for clinical trials. Otolaryngol Head Neck Surg (2006) 0.95

Prevalence of COPD in Abu Dhabi, United Arab Emirates. Respir Med (2011) 0.94

Population prevalence of asthma and its determinants based on European Community Respiratory Health Survey in the United Arab Emirates. BMC Pulm Med (2012) 0.93

Survey on the impact of comorbid allergic rhinitis in patients with asthma. BMC Pulm Med (2006) 0.92

Asthma insights and reality in Turkey (AIRET) study. Respir Med (2006) 0.92

Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD. Respir Med (2004) 0.92

IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion. Acta Otolaryngol (2003) 0.92

Allergic rhinitis and asthma: the link, the new ARIA classification and global approaches to treatment. Curr Opin Allergy Clin Immunol (2004) 0.90

Investigating the natural history of lung function: facts, pitfalls, and opportunities. Chest (2009) 0.89

Association between obstructive sleep apnea and pulmonary embolism. Mayo Clin Proc (2013) 0.89

Synergistic induction of thymic stromal lymphopoietin by tumor necrosis factor alpha and Th2 cytokine in nasal polyp fibroblasts. Am J Rhinol Allergy (2010) 0.89

Chronic obstructive pulmonary disease with lung cancer and/or cardiovascular disease. Proc Am Thorac Soc (2008) 0.89

Effectiveness of pulmonary rehabilitation in reducing health resources use in chronic obstructive pulmonary disease. Arch Phys Med Rehabil (2010) 0.88

Chronic obstructive pulmonary disease history assessment in Spain: a multidimensional chronic obstructive pulmonary disease evaluation. Study methods and organization. Arch Bronconeumol (2012) 0.87

Cochlin-tomoprotein: a novel perilymph-specific protein and a potential marker for the diagnosis of perilymphatic fistula. Audiol Neurootol (2009) 0.86

Cochlin-tomoprotein (CTP) detection test identifies traumatic perilymphatic fistula due to penetrating middle ear injury. Acta Otolaryngol (2011) 0.86

Increased expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and matrix metalloproteinase-13 in lesional skin of bullous pemphigoid. Int Arch Allergy Immunol (2005) 0.86

Expression and Roles of MMP-2, MMP-9, MMP-13, TIMP-1, and TIMP-2 in Allergic Nasal Mucosa. Allergy Asthma Immunol Res (2012) 0.86

Allergic rhinitis: current options and future perspectives. Curr Opin Allergy Clin Immunol (2014) 0.85

Expression of cochlin in the vestibular organ of rats. ORL J Otorhinolaryngol Relat Spec (2005) 0.85

Expression of cochlin mRNA splice variants in the inner ear. Audiol Neurootol (2009) 0.85

Induction of TARC production by lipopolysaccharide and interleukin-4 in nasal fibroblasts. Int Arch Allergy Immunol (2007) 0.85

Nasal polyp fibroblasts produce MIP-3alpha in response to toll-like receptor ligands and cytokine stimulation. Rhinology (2010) 0.85

Case-finding of chronic obstructive pulmonary disease with questionnaire, peak flow measurements and spirometry: a cross-sectional study. BMC Res Notes (2014) 0.84

Rhinosinusitis and asthma-microbiome and new perspectives. Curr Opin Allergy Clin Immunol (2013) 0.84

100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco. Int Arch Allergy Immunol (2012) 0.83

Asthma Control in Oman: National Results within the Asthma Insights and Reality in the Gulf and the Near East (AIRGNE) Study. Sultan Qaboos Univ Med J (2011) 0.83

Factors associated with mortality in patients with exacerbation of chronic obstructive pulmonary disease hospitalized in General Medicine departments. Intern Emerg Med (2010) 0.83

A comprehensive, national survey of spirometry in Spain: current bottlenecks and future directions in primary and secondary care. Chest (2013) 0.83

Adherence to asthma treatments: 'we know, we intend, we advocate'. Curr Opin Allergy Clin Immunol (2015) 0.82

"Causes of death in asthma, COPD and non-respiratory hospitalized patients: a multicentric study". BMC Pulm Med (2013) 0.82

Synergistic Induction of Macrophage Inflammatory Protein-3α;/CCL20 Production by Interleukin-17A and Tumor Necrosis Factor-α; in Nasal Polyp Fibroblasts. World Allergy Organ J (2009) 0.82

The unmet global health need of severe and complex allergies: meeting the challenge. World Allergy Organ J (2012) 0.82

Ultrastructural co-localization of cochlin and type II collagen in the rat semicircular canal. Neurosci Lett (2008) 0.82

Prevalence, Risk Factors and Diagnostic Accuracy of COPD Among Smokers in Primary Care. COPD (2015) 0.81

Identification and diversity of multiresistant Corynebacterium striatum clinical isolates by MALDI-TOF mass spectrometry and by a multigene sequencing approach. BMC Microbiol (2012) 0.81

One year weight loss in the TRAMOMTANA study. A randomized controlled trial. Clin Endocrinol (Oxf) (2013) 0.81

Recent epidemiological trends in tuberculous pleural effusion in Galicia, Spain. Eur J Intern Med (2012) 0.81

InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients--the LIAISON study protocol. BMC Pulm Med (2013) 0.81

The management of paediatric allergy: not everybody's cup of tea--10-11th February 2012. Curr Opin Allergy Clin Immunol (2013) 0.81

Inflammatory mechanisms in allergic rhinitis. Curr Opin Allergy Clin Immunol (2007) 0.81

Epithelial cells as immunoregulators in allergic airway diseases. Curr Opin Allergy Clin Immunol (2002) 0.80

The performance of Cochlin-tomoprotein detection test in the diagnosis of perilymphatic fistula. Audiol Neurootol (2009) 0.80

Differential effects of smoking and COPD upon circulating myeloid derived suppressor cells. Respir Med (2013) 0.80